Literature DB >> 30723874

Combining Omalizumab with Another Biotherapy.

Anne-Claire Fougerousse1, Pierre-André Becherel, Valérie Pallure, Thierry Boyé, Ziad Reguiai, Germaine Gabison, Hughes Barthelemy, Antoine Badaoui, Emmanuel Mahé, Cristina Bulai Livideanu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30723874     DOI： 10.2340/00015555-3140

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  1 in total

1.  Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases.

Authors:  Mitchell M Pitlick; Thanai Pongdee
Journal:  World Allergy Organ J       Date:  2022-10-13       Impact factor: 5.516
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.